Guangzhou Micro-Nano
Chinese semiconductor industry
- Thread starter Hendrik_2000
- Start date
- Status
any idea who they are supplying so far? this is the first time I've heard of them anywhere
Guangzhou Micro-Nano Lithography Materials Technology Co., Ltd. was founded in 2020. It is the only high-tech company in Guangdong Province that specializes in developing 193nm photoresist and related materials for high-end semiconductor chip manufacturing in the 90nm-55nm process. It is a member of SMIC, Guangzhou Guangdong Core companies and other customers customize photoresist.
The company's ArF domestic photoresist research and development project began in 2016. The founder first independently developed the photoresist resin company founded in Hengqin, Zhuhai. The formula is used on ASML lithography machines (90nm, 90nm, 65nm, 55nm) has conducted a large number of evaluations. The key technical indicators of its ArF photoresist, such as DOF, have surpassed the existing top echelon commercial products and is in a leading position in the country. The headquarters is located in Huangpu District (Development Zone), Guangzhou, and has R&D centers and laboratories in Zhuhai and Shanghai.
product description:
Guangwei Nano Company has registered the "Nake" trademark and formed a series of photoresist products called "Nake". Our company's photoresist technology is 100% developed locally and has completely independent intellectual property rights. Among them, in the ArF photoresist series, there is ArF dry photoresist with excellent performance. After evaluation at SMIC's Beijing 55 nm node production line, the result is that the DOF is greater than 300 nm@ 81 nm L/S, which is better than the existing commercial ArF dry photoresist.
In terms of raw materials: the company has the right to use the patented technology of ArF photosensitive resin and photosensitizer used in the product. All photolithographic collagen materials are exclusively supplied by the Zhuhai company, ensuring exclusive competitiveness.
antiterror13
Brigadier
456 B Yuan is roughly US$62B or if extrapolated to 1 year, it would be US$83B .. don't know, somehow I thought it was more than US$100B. The profit is good 73.05 B yuan or roughly US$10B
.
Honor and a few businesses were sold so total revenue is less than $100B. But Huawei should have over $100B revenue next year. As for profit, Huawei has poured so much money into R&D for the last few years that $10B profit is not the full potential of Huawei.
antiterror13
Brigadier
R&D is not the same of expenses, it is capitalised and amortised over time. So R&D is in balance sheet, not in P & L (the amortisation of R&D is in P&L)
Prior to 2022, US companies can fully deduct R&D costs as expense. As of 1/1/2022, companies are now required to capitalize and amortize the cost of R&D expenditures.
However, under US GAAP's reporting requirements(ASC 730), R&D will continue to be expensed as incurred. Starting 2022, R&D for the tax purpose is required capitalized and amortized but R&D for US GAAP accounting reporting purpose will continue to be expensed when the cost incurred. For China, 80% of Chinese companies adopt expensing R&D approach.
That's a very surprising result given that Mate60 sale has been supposedly so good in September. The revenue barely ticked up at all in Q3. The tick up in net profit could be partially attributed to balance from sale of Honor three years ago.
I was expecting better financial result from Huawei.
Last edited:
antiterror13
Brigadier
great, didn't know that. In NZ R&D is in balance sheet
I am assuming Huawei is in 80% of Chinese companies ?
- Status